Insider Selling: Jonathan S. Wolfson Sells 30,000 Shares of Solazyme Stock (SZYM)
Solazyme (NASDAQ:SZYM) CEO Jonathan S. Wolfson sold 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 21st. The stock was sold at an average price of $9.09, for a total transaction of $272,700.00. Following the transaction, the chief executive officer now directly owns 282,500 shares in the company, valued at approximately $2,567,925. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
A number of research firms have recently commented on SZYM. Analysts at Credit Suisse cut their price target on shares of Solazyme from $12.00 to $11.00 in a research note on Wednesday, April 2nd. Separately, analysts at Cowen and Company raised their price target on shares of Solazyme from $17.00 to $18.00 in a research note on Tuesday, April 1st. Finally, analysts at Robert W. Baird cut their price target on shares of Solazyme from $18.00 to $16.00 in a research note on Friday, March 28th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $14.50.
Shares of Solazyme (NASDAQ:SZYM) traded down 1.16% on Friday, hitting $9.41. The stock had a trading volume of 706,708 shares. Solazyme has a 1-year low of $8.00 and a 1-year high of $15.00. The stock’s 50-day moving average is $10.33 and its 200-day moving average is $10.61. The company’s market cap is $714.9 million.
Solazyme (NASDAQ:SZYM) last posted its quarterly earnings results on Monday, May 5th. The company reported ($0.44) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.33) by $0.11. The company had revenue of $12.40 million for the quarter, compared to the consensus estimate of $14.63 million. During the same quarter last year, the company posted ($0.43) earnings per share. Solazyme’s revenue was up 85.1% compared to the same quarter last year. Analysts expect that Solazyme will post $-1.52 EPS for the current fiscal year.
Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.